Guangzhou Kingmed Diagnostics Group Co. Ltd. logo

Guangzhou Kingmed Diagnostics Group Co. Ltd. (603882)

Market Closed
12 Dec, 06:57
SSE SSE
¥
27. 93
-0.1
-0.36%
¥
15.74B Market Cap
- P/E Ratio
3.52% Div Yield
3,034,570 Volume
- Eps
¥ 28.03
Previous Close
Day Range
27.83 28.18
Year Range
24.35 42
Want to track 603882 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603882 closed Friday lower at ¥27.93, a decrease of 0.36% from Thursday's close, completing a monthly decrease of -2% or ¥0.57. Over the past 12 months, 603882 stock gained 1.34%.
603882 is not paying dividends to its shareholders.
The last earnings report, released on Aug 22, 2025, missed the consensus estimates by -0.05%. On average, the company has fell short of earnings expectations by -0.11%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on SSE (CNY).

603882 Chart

Similar

Nari Technology Co., Ltd.
¥ 23.2
+2.11%
WuXi AppTec Co., Ltd.
¥ 93.39
-0.01%
Sany Heavy Industry Co., Ltd.
¥ 21.28
+0.9%
China CSSC Holdings Ltd.
¥ 34.31
+0.65%
China Communications Construction Co., Ltd.
¥ 8.43
-0.12%

Guangzhou Kingmed Diagnostics Group Co. Ltd. (603882) FAQ

What is the stock price today?

The current price is ¥27.93.

On which exchange is it traded?

Guangzhou Kingmed Diagnostics Group Co. Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603882.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.52%.

What is its market cap?

As of today, the market cap is 15.74B.

Has Guangzhou Kingmed Diagnostics Group Co. Ltd. ever had a stock split?

No, there has never been a stock split.

Guangzhou Kingmed Diagnostics Group Co. Ltd. Profile

Professional Services Industry
Industrials Sector
Mr. Yaoming Liang CEO
SSE Exchange
CNE100002VW1 ISIN
CN Country
11,586 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Guangzhou Kingmed Diagnostics Group Co., Ltd., established in 2006, is a premier provider of medical diagnosis services in China. With its headquarters located in Guangzhou, China, the company has grown to offer a wide range of services that extend beyond traditional diagnostics. It has integrated advanced technologies such as big data and artificial intelligence into its operations, catering to both medical and research needs. Their services are not limited to the health sector but also include scientific research, offering a broad spectrum of applications from clinical research to forensic testing.

Products and Services

  • Clinical Research - Guangzhou Kingmed Diagnostics engages in extensive clinical research, contributing to the advancement of medical science. This involves the testing and development of new treatments and medications, ensuring they are safe and effective for patient care.
  • Health Management - The company provides comprehensive health management services. This encompasses a range of preventative care measures, diagnostics, and personalized health solutions designed to improve overall well-being.
  • Cold Chain Logistics - Specializing in cold chain logistics, Guangzhou Kingmed guarantees the safe transport of temperature-sensitive medical and scientific materials, ensuring they remain uncompromised from point A to point B.
  • Scientific Research Services - This facet of the company focuses on supporting scientific investigations, providing essential resources and expertise for groundbreaking research in various scientific fields.
  • In Vitro Diagnostics - Offering state-of-the-art in vitro diagnostics solutions, the company enables the detection of diseases and infections through direct analysis of samples outside the human body, promoting faster and more accurate diagnoses.
  • Big Data - Guangzhou Kingmed leverages big data analytics to process and analyze large volumes of data. This aids in identifying patterns, trends, and insights, which can significantly improve healthcare outcomes, operational efficiency, and strategic planning.
  • Artificial Intelligence (AI) - The application of AI technologies enhances the accuracy of diagnoses, streamlines operational processes, and facilitates the development of personalized medicine, propelling healthcare into the future.
  • Forensic Testing Services - The company also extends its expertise to the field of forensic testing, offering reliable services for criminal and legal investigations. This includes DNA testing, substance analysis, and other forensic examinations.

Contact Information

Address: No. 10, Spiral 3rd Road, Guangzhou, China, 510000
Phone: 86 20 2919 6326